NIOX Group (LON:NIOX) Trading 3.4% Higher – Should You Buy?

NIOX Group Plc (LON:NIOX) shares shot up 3.4% during trading on Tuesday . The company traded as high as GBX 59.17 and last traded at GBX 59.17. 2,496,140 shares were traded during mid-day trading, an increase of 191% from the average daily volume of 856,313 shares. The stock had previously closed at GBX 57.20.

NIOX Group Price Performance

The company has a 50 day moving average price of GBX 59.34 and a 200 day moving average price of GBX 61.96. The company has a market capitalization of £249.03 million, a price-to-earnings ratio of 36.08 and a beta of 0.92. The company has a current ratio of 3.81, a quick ratio of 1.94 and a debt-to-equity ratio of 1.36.

Insider Buying and Selling at NIOX Group

In related news, insider Jonathan Emms sold 325,273 shares of NIOX Group stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of GBX 56, for a total value of £182,152.88. Also, insider Sarah Duncan sold 164,612 shares of the business’s stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of GBX 56, for a total value of £92,182.72. In the last ninety days, insiders have bought 102,805 shares of company stock worth $5,996,817 and have sold 662,056 shares worth $37,453,394. Corporate insiders own 5.11% of the company’s stock.

About NIOX Group

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.